|
MARS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.723200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.378780E-01 |
| Normal-vs-Stage2 |
3.332600E-01 |
| Normal-vs-Stage3 |
4.493000E-01 |
| Normal-vs-Stage4 |
2.058600E-01 |
| Stage1-vs-Stage2 |
9.517600E-01 |
| Stage1-vs-Stage3 |
3.627500E-02 |
| Stage1-vs-Stage4 |
7.675300E-03 |
| Stage2-vs-Stage3 |
1.447420E-01 |
| Stage2-vs-Stage4 |
6.985600E-02 |
| Stage3-vs-Stage4 |
6.610000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.875600E-01 |
| Normal-vs-AfricanAmerican |
4.942400E-01 |
| Normal-vs-Asian |
4.573400E-01 |
| Caucasian-vs-AfricanAmerican |
4.423600E-01 |
| Caucasian-vs-Asian |
6.188000E-01 |
| AfricanAmerican-vs-Asian |
2.868000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.307400E-01 |
| Normal-vs-Female |
2.830200E-01 |
| Male-vs-Female |
1.358200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.609030E-01 |
| Normal-vs-Age(41-60Yrs) |
6.855800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.358600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.955400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.557700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.045800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.310800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.834800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.266800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.412600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.370300E-02 |
| Classical-VS-Follicular |
8.231600E-01 |
| Classical-VS-Other |
1.963190E-01 |
| Classical-VS-Normal |
2.267200E-01 |
| Tall-VS-Follicular |
9.168000E-02 |
| Tall-VS-Other |
7.712600E-01 |
| Tall-VS-Normal |
1.191360E-01 |
| Follicular-VS-Other |
3.655600E-01 |
| Follicular-VS-Normal |
5.742400E-01 |
| Other-VS-Normal |
1.716420E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.108200E-01 |
| Normal-vs-N1 |
5.109600E-01 |
| N0-vs-N1 |
2.598200E-01 |
|
|
